Daisuke Yokota

871 total citations
40 papers, 643 citations indexed

About

Daisuke Yokota is a scholar working on Surgery, Molecular Biology and Hematology. According to data from OpenAlex, Daisuke Yokota has authored 40 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Daisuke Yokota's work include Coronary Interventions and Diagnostics (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Dermatology and Skin Diseases (4 papers). Daisuke Yokota is often cited by papers focused on Coronary Interventions and Diagnostics (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Dermatology and Skin Diseases (4 papers). Daisuke Yokota collaborates with scholars based in Japan, Spain and Norway. Daisuke Yokota's co-authors include Hidehisa Saeki, Hidetsugu Tsubouchi, Kazunori Ohnishi, Kenya Nasu, Masashi Kimura, Tairo Kurita, Tsuyoshi Ito, Etsuo Tsuchikane, Maoto Habara and Takahiko Suzuki and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Applied Physics Letters.

In The Last Decade

Daisuke Yokota

35 papers receiving 632 citations

Peers

Daisuke Yokota
Franklin Schlerman United States
Takanori Maruyama Japan
Åse Bratland Norway
M López Italy
Anu Autio Finland
Alessia Bertolotti Italy
Tímea Besenyei Hungary
Marta K. Taylor United States
Shigehiko Nishimura Japan
Murat Serilmez Türkiye
Franklin Schlerman United States
Daisuke Yokota
Citations per year, relative to Daisuke Yokota Daisuke Yokota (= 1×) peers Franklin Schlerman

Countries citing papers authored by Daisuke Yokota

Since Specialization
Citations

This map shows the geographic impact of Daisuke Yokota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Yokota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Yokota more than expected).

Fields of papers citing papers by Daisuke Yokota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Yokota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Yokota. The network helps show where Daisuke Yokota may publish in the future.

Co-authorship network of co-authors of Daisuke Yokota

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Yokota. A scholar is included among the top collaborators of Daisuke Yokota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Yokota. Daisuke Yokota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamashita, Shizuya, et al.. (2025). Efficacy and Safety of Bempedoic Acid for Hypercholesterolemia in Japan: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Trial. Journal of Atherosclerosis and Thrombosis. 32(8). 1053–1070. 2 indexed citations
2.
Akiyama, Tsuyoshi, Yuta Ito, Daisuke Yokota, et al.. (2025). Boosting the Stability of FAPbI 3 Perovskite Nanocrystal Near‐Infrared Light‐Emitting Diodes with Aromatic Ligands and Organic Host Dispersion. Small. 21(31). e2501159–e2501159.
3.
4.
Yokota, Daisuke, et al.. (2024). Highly stable and bright CsPbI3 nanocrystal red emitters based on color-conversion from InGaN-based blue light-emitting diodes. Applied Physics Letters. 125(13). 2 indexed citations
5.
Fujioka, Yuki, et al.. (2023). Endovascular Retrieval of a Fractured Tunneled Hemodialysis Central Venous Catheter Using the Loop Snare Technique. Cureus. 15(2). e35617–e35617. 1 indexed citations
6.
Sugimoto, Takayuki, Takuya Hashimoto, Takato Takemura, Daisuke Yokota, & Hiroki Fujimori. (2023). Fabrication of aluminum titanate–glass composites with controlled thermal expansion and improved mechanical strength. Ceramics International. 49(12). 20784–20791. 2 indexed citations
7.
Saeki, Hidehisa, Tomomi Imamura, Daisuke Yokota, & Hidetsugu Tsubouchi. (2022). Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study. Dermatology and Therapy. 12(7). 1589–1601. 19 indexed citations
8.
Ebisawa, Soichiro, Takashi Miura, Daisuke Yokota, et al.. (2021). Body composition and mortality in patients undergoing endovascular treatment for peripheral artery disease. Heart and Vessels. 36(12). 1830–1840. 3 indexed citations
9.
Saeki, Hidehisa, et al.. (2021). Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial. Journal of the American Academy of Dermatology. 86(3). 607–614. 52 indexed citations
10.
Kinoshita, Hirofumi, Taijiro Yabe, Daisuke Yokota, et al.. (2018). Functional roles of the Ripply-mediated suppression of segmentation gene expression at the anterior presomitic mesoderm in zebrafish. Mechanisms of Development. 152. 21–31. 7 indexed citations
11.
Yokota, Daisuke, et al.. (2016). Enhancer activity-based identification of functional enhancers using zebrafish embryos. Genomics. 108(2). 102–107. 6 indexed citations
12.
Kawamura, Akinori, Hirofumi Kinoshita, Daisuke Yokota, et al.. (2015). Posterior–anterior gradient of zebrafish hes6 expression in the presomitic mesoderm is established by the combinatorial functions of the downstream enhancer and 3′UTR. Developmental Biology. 409(2). 543–554. 5 indexed citations
13.
Nasu, Kenya, Mitsuyasu Terashima, Maoto Habara, et al.. (2013). Impact of Cholesterol Metabolism on Coronary Plaque Vulnerability of Target Vessels. JACC: Cardiovascular Interventions. 6(7). 746–755. 35 indexed citations
14.
Habara, Maoto, Mitsuyasu Terashima, Kenya Nasu, et al.. (2012). Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study. European Heart Journal - Cardiovascular Imaging. 14(3). 276–284. 69 indexed citations
15.
Teramoto, Tomohiko, Tatsuya Ito, Etsuo Tsuchikane, et al.. (2012). PRIOR CORONARY ARTERY BYPASS GRAFTING DIMINISH THE INITIAL SUCCESS RATE OF PERCUTANEOUS CORONARY INTERVENTION TO THE CHRONIC TOTAL OCCLUSION IN THE NATIVE CORONARY ARTERY. Journal of the American College of Cardiology. 59(13). E104–E104. 4 indexed citations
16.
Ito, Tatsuya, Nobuyoshi Tanaka, Daisuke Yokota, et al.. (2011). LONG-TERM OUTCOMES OF CORONARY ARTERY BYPASS GRAFTING OR PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENT FOR THREE-VESSEL CORONARY ARTERY DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal of the American College of Cardiology. 57(14). E1899–E1899. 1 indexed citations
17.
Nakamura, Satoki, Daisuke Yokota, Lin Tan, et al.. (2011). Down‐regulation of Thanatos‐associated protein 11 by BCR‐ABL promotes CML cell proliferation through c‐Myc expression. International Journal of Cancer. 130(5). 1046–1059. 22 indexed citations
18.
19.
Nakamura, Satoki, Mitsuji Yamashita, Daisuke Yokota, et al.. (2009). Development and pharmacologic characterization of deoxybromophospha sugar derivatives with antileukemic activity. Investigational New Drugs. 28(4). 381–391. 20 indexed citations
20.
Sugiyama, Toru, et al.. (1990). An experimental model for advanced ovarian cancer.. The Kurume Medical Journal. 37(1). 15–21. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franklin Schlerman Breakdown of academic impact, for papers by Takanori Maruyama Breakdown of academic impact, for papers by Åse Bratland Breakdown of academic impact, for papers by M López Breakdown of academic impact, for papers by Anu Autio Breakdown of academic impact, for papers by Alessia Bertolotti Breakdown of academic impact, for papers by Tímea Besenyei Breakdown of academic impact, for papers by Marta K. Taylor Breakdown of academic impact, for papers by Shigehiko Nishimura Breakdown of academic impact, for papers by Murat Serilmez
Rankless by CCL
2026